[ Price : $8.95]
Federal Register Notice: FDA submits a collection of information on its public health notification readership survey to the Office...[ Price : $8.95]
Dendreon submits an amended BLA to FDA for its controversial prostate cancer drug Provenge.[ Price : $8.95]
FDA issues GTx, Inc. a complete response letter on an NDA for toremifene 80 mg, indicated for reducing fractures in men with prost...[ Price : $8.95]
FDA warns Procter & Gamble that it is illegally marketing DayQuil Plus Vitamin C and Nyquil Plus Vitamin C as combination drug and...